Miranda Schmalfuhs

home / authors / miranda-schmalfuhs

Articles

Pharma Pulse 7/3/24: Reactions to New FDA Diversity Action Plan Guidance, Walgreens Strengthens Support for Children and Adults Living with Diabetes & more

Pharma Pulse 7/3/24: Reactions to New FDA Diversity Action Plan Guidance, Walgreens Strengthens Support for Children and Adults Living with Diabetes & more

Miranda Schmalfuhs
July 3rd 2024
Pharma Pulse 7/2/24: AI’s Promise in Delivering on Patient-Centricity, What’s Complicating Good Data Practices and Data Integrity? & more

Pharma Pulse 7/2/24: AI’s Promise in Delivering on Patient-Centricity, What’s Complicating Good Data Practices and Data Integrity? & more

Miranda Schmalfuhs
July 2nd 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/1/24: How Can Incoming, Existing Executives Build a Sustainable Role?

Pharma Pulse 7/1/24: How Can Incoming, Existing Executives Build a Sustainable Role?

Miranda Schmalfuhs
July 1st 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/28/24: Pharmacy Closure Contributors, The Long-Term Consequences & more

Pharma Pulse 6/28/24: Pharmacy Closure Contributors, The Long-Term Consequences & more

Miranda Schmalfuhs
June 28th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/27/24: Pharmacy Deserts & Underserved/Rural Communities, GoodRx Launches New “Prescription Cost Tracker” & more

Pharma Pulse 6/27/24: Pharmacy Deserts & Underserved/Rural Communities, GoodRx Launches New “Prescription Cost Tracker” & more

Miranda Schmalfuhs
June 27th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/26/24: How to Thrive in a Cookie-Less Era, Why Consumers are Switching Providers and Payers & more

Pharma Pulse 6/26/24: How to Thrive in a Cookie-Less Era, Why Consumers are Switching Providers and Payers & more

Miranda Schmalfuhs
June 26th 2024

The latest news for pharma industry insiders.

Pharma pulse 6/25/24: Novo Nordisk Invests $4.1 billion to Expand US Manufacturing, Improving the Efficacy of Genetic Medicines & more

Pharma pulse 6/25/24: Novo Nordisk Invests $4.1 billion to Expand US Manufacturing, Improving the Efficacy of Genetic Medicines & more

Miranda Schmalfuhs
June 25th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/24/24: Accelerating Clinical Trial Activation, Humans Need to Be Factored Into AI Trust and Acceptance & more

Pharma Pulse 6/24/24: Accelerating Clinical Trial Activation, Humans Need to Be Factored Into AI Trust and Acceptance & more

Miranda Schmalfuhs
June 24th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/21/24: Global Mortality and Disability from Type 1 Diabetes Have Decreased, What Leaders of Effective Teams Know & more

Pharma Pulse 6/21/24: Global Mortality and Disability from Type 1 Diabetes Have Decreased, What Leaders of Effective Teams Know & more

Miranda Schmalfuhs
June 21st 2024
Pharma Pulse 6/20/24: Talkspace and FitOn Team Up, The Potential of CAR-T Therapies & more

Pharma Pulse 6/20/24: Talkspace and FitOn Team Up, The Potential of CAR-T Therapies & more

Miranda Schmalfuhs
June 20th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/19/24: DIA 2024 Coverage, How Orange Peels Connect to Heart Health & more

Pharma Pulse 6/19/24: DIA 2024 Coverage, How Orange Peels Connect to Heart Health & more

Miranda Schmalfuhs
June 19th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/18/24: ADHD Opportunity Assessment and Forecasts, Ensuring Ethical GLP-1 Practices & more

Pharma Pulse 6/18/24: ADHD Opportunity Assessment and Forecasts, Ensuring Ethical GLP-1 Practices & more

Miranda Schmalfuhs
June 18th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/17/24: Pet Care Industry Eyes GLP-1s, Improving Quality of Care for Cancer Patients & more

Pharma Pulse 6/17/24: Pet Care Industry Eyes GLP-1s, Improving Quality of Care for Cancer Patients & more

Miranda Schmalfuhs
June 17th 2024
Pharma Pulse 6/14/24: Weight Loss Drug Shortages Prompt Shortage Tracking Platforms, Build Trust with Patients to Overcome Misinformation & more

Pharma Pulse 6/14/24: Weight Loss Drug Shortages Prompt Shortage Tracking Platforms, Build Trust with Patients to Overcome Misinformation & more

Miranda Schmalfuhs
June 14th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/13/24: IQVIA Launches “One Home” Platform, Coverage for GLP-1 Drugs for Obesity is in Flux & more

Pharma Pulse 6/13/24: IQVIA Launches “One Home” Platform, Coverage for GLP-1 Drugs for Obesity is in Flux & more

Miranda Schmalfuhs
June 13th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/12/24: The Healthcare System is Changing—So How Should We Respond?, What the Apple-OpenAI Deal Means for Four Tech Titans & more

Pharma Pulse 6/12/24: The Healthcare System is Changing—So How Should We Respond?, What the Apple-OpenAI Deal Means for Four Tech Titans & more

Miranda Schmalfuhs
June 12th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/11/24: How Moderna is Implementing AI and ChatGPT, Managing Palliative Care Challenges for Patients with Complex Symptoms & more

Pharma Pulse 6/11/24: How Moderna is Implementing AI and ChatGPT, Managing Palliative Care Challenges for Patients with Complex Symptoms & more

Miranda Schmalfuhs
June 11th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/10/24: Sustainability in Clinical Trials, Merck Bets on AI Drug-Design Partnerships & more

Pharma Pulse 6/10/24: Sustainability in Clinical Trials, Merck Bets on AI Drug-Design Partnerships & more

Miranda Schmalfuhs
June 10th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/7/24: Mark Cuban Talks Drug Pricing, Cost Remains Barrier to Respiratory Care for Patients & more

Pharma Pulse 6/7/24: Mark Cuban Talks Drug Pricing, Cost Remains Barrier to Respiratory Care for Patients & more

Miranda Schmalfuhs
June 7th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/6/24: OpenAI Insiders Warn of a ‘Reckless’ Race for Dominance, Three Ways to Close the Urgent Talent Gap & more

Pharma Pulse 6/6/24: OpenAI Insiders Warn of a ‘Reckless’ Race for Dominance, Three Ways to Close the Urgent Talent Gap & more

Miranda Schmalfuhs
June 6th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/5/24: Polypharmacy and the Pivotal Role of the Payer, Patients and Data Disrupt the Industry & more

Pharma Pulse 6/5/24: Polypharmacy and the Pivotal Role of the Payer, Patients and Data Disrupt the Industry & more

Miranda Schmalfuhs
June 5th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/4/24: Differentiating Consumer- & Medical-Grade Wearables, Is Your Serialization Program Sustainable? & more

Pharma Pulse 6/4/24: Differentiating Consumer- & Medical-Grade Wearables, Is Your Serialization Program Sustainable? & more

Miranda Schmalfuhs
June 4th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/3/24: New ChatGPT Offers Lesson in AI Hype, Managing Diversity & more

Pharma Pulse 6/3/24: New ChatGPT Offers Lesson in AI Hype, Managing Diversity & more

Miranda Schmalfuhs
June 3rd 2024

The latest news for pharma industry insiders.

Pharma Pulse 5/31/24: Gen Z’s Passion for Skincare Falls Short on Sun Protection, A Long, But Promising Road Ahead in Clinical Trials & more

Pharma Pulse 5/31/24: Gen Z’s Passion for Skincare Falls Short on Sun Protection, A Long, But Promising Road Ahead in Clinical Trials & more

Miranda Schmalfuhs
May 31st 2024

The latest news for pharma industry insiders.

Pharma Pulse 5/30/24: Merck to Acquire EyeBio, Financial Burden of Private Healthcare Increased Over the Past Two Decades & more

Pharma Pulse 5/30/24: Merck to Acquire EyeBio, Financial Burden of Private Healthcare Increased Over the Past Two Decades & more

Miranda Schmalfuhs
May 30th 2024

The latest news for pharma industry insiders.

Pharma Pulse 5/29/24: OpenAI Forms New Committee to Evaluate Safety/Security, Proposed FDA Rule Could Limit Pharmacy Compounding & more

Pharma Pulse 5/29/24: OpenAI Forms New Committee to Evaluate Safety/Security, Proposed FDA Rule Could Limit Pharmacy Compounding & more

Miranda Schmalfuhs
May 29th 2024

The latest news for pharma industry insiders.

Pharma Pulse 5/28/24: Global Insulin Delivery Systems Strategic Research Report 2024, A Fun and Insightful Exploration of Behavioral Science & more

Pharma Pulse 5/28/24: Global Insulin Delivery Systems Strategic Research Report 2024, A Fun and Insightful Exploration of Behavioral Science & more

Miranda Schmalfuhs
May 28th 2024

The latest news for pharma industry insiders.

Pharma Pulse 5/27/24: Cyberattack at Ascension Hospitals Causing Delays in Patient Care, Optimizing Pharmaceutical Innovation Through AI & more

Pharma Pulse 5/27/24: Cyberattack at Ascension Hospitals Causing Delays in Patient Care, Optimizing Pharmaceutical Innovation Through AI & more

Miranda Schmalfuhs
May 27th 2024

The latest news for pharma industry insiders.

Pharma Pulse 5/24/24: Pre-Approval Information Exchange to Accelerate Product Success, Walgreens Boots Alliance Sells Shares of Cencora & more

Pharma Pulse 5/24/24: Pre-Approval Information Exchange to Accelerate Product Success, Walgreens Boots Alliance Sells Shares of Cencora & more

Miranda Schmalfuhs
May 24th 2024

The latest news for pharma industry insiders.

Pharma Pulse 5/23/24: Implications for Drug Shortages and Patient Care,  How Businesses Are Customizing AI Models & more

Pharma Pulse 5/23/24: Implications for Drug Shortages and Patient Care,  How Businesses Are Customizing AI Models & more

Miranda Schmalfuhs
May 23rd 2024

The latest news for pharma industry insiders.

<12345678>

Latest Updated Articles

Trade & Channel Strategies 2024: A GTN Bubble Balancing Act
Published: December 16th 2024 | Updated: December 21st 2024
Trade & Channel Strategies 2024: A GTN Bubble Balancing Act
The Gap in DSCSA Readiness
Published: December 9th 2024 | Updated: December 21st 2024
The Gap in DSCSA Readiness
Beyond the Finish Line: Why Post-Approval Regulatory Strategy Matters
Published: September 16th 2024 | Updated: December 21st 2024
Beyond the Finish Line: Why Post-Approval Regulatory Strategy Matters
Measuring Time Burdens Around Cancer Care
Published: December 4th 2024 | Updated: December 21st 2024
Measuring Time Burdens Around Cancer Care
Adragos Pharma Acquires Baccinex, Growing Sterile Manufacturing Services
Published: November 29th 2024 | Updated: December 21st 2024
Adragos Pharma Acquires Baccinex, Growing Sterile Manufacturing Services
Skills Needed to Thrive in the Evolving Industry Landscape
Published: November 22nd 2024 | Updated: December 21st 2024
Skills Needed to Thrive in the Evolving Industry Landscape
© 2024 MJH Life Sciences

All rights reserved.